TSM-associated metabolomic signature

Biomarker

1 paper2 findings

  • Humans1

Effects

1

SCORE2

upin humans1

1 study
  1. TSM-associated metabolomic signature improves SCORE2 in humans (AUC 0.584 to 0.660).

    “Adding TSM or the metabolomic signature to SCORE2 improved 10‐year risk discrimination (area under the curve 0.584 to 0.657 and 0.660, respectively)”

    Humansfemalesn = 67,582

    Integrating menopause duration and plasma metabolomics enhances cardiovascular risk stratification in aging women

    npj aging6 Jan 2026

More on SCORE2

Associations

1

Cardiovascular disease

upin humans1HR 1.18

1 study
  1. TSM-associated metabolomic signature raises the risk of cardiovascular disease in humans (HR 1.18, 95% CI 1.15-1.21 per 1-SD increase).

    “each 1-standard deviation increases in the metabolomic signature (HR 1.18, 95% CI 1.15-1.21) were independently associated with higher composite CVD risk”

    Humansfemalesn = 67,582

    Integrating menopause duration and plasma metabolomics enhances cardiovascular risk stratification in aging women

    npj aging6 Jan 2026

More on Cardiovascular disease

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months